{"database": "lobbying", "table": "lobbying_activities", "rows": [[748461, "563cb106-b79e-4569-bc1e-b24c9eab57dc", "1T", "THE WERNER GROUP", 298557, "SHIRE PHARMACEUTICALS", 2009, "first_quarter", "MED", "HR 1548  Pathway for Biosimilars Act -- focus on orphan drug issues\nHR 1427  Promoting Innovation and Access to Life Saving Medicine Act -- focus on orphan drug issues", "HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 1, "2009-04-14T11:09:57-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["748461"], "units": {}, "query_ms": 0.532663005287759, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}